Shattuck Labs, Inc. Weighted Average Number of Shares, Contingently Issuable
Shattuck Labs, Inc. (STTK) reported Weighted Average Number of Shares, Contingently Issuable of 3.10 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable · last filed 2024-05-02
- Shattuck Labs, Inc. weighted average number of shares, contingently issuable for the quarter ending 2024-03-31 was 3.10M shares.
| Period end | Weighted Average Number of Shares, Contingently Issuable 3 month |
|---|---|
| 2024-03-31 | 3.10M shares 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |